Chronic Pain

New Hampshire Doctor Named 2018 Family Physician of the Year

Chronic Pain - Wed, 09/20/2017 - 10:40

SAN ANTONIO, Sept. 20, 2017 : The American Academy of Family Physicians today awarded its highest honor to Gerard J. Hevern, MD, FAAFP, of Suncook, New Hampshire.

Categories: Chronic Pain

Between 39 and 85 percent of the HIV population experiences chronic pain.

Chronic Pain - Tue, 09/19/2017 - 20:33

Recognizing that 39 to 85 percent of those living with HIV suffer from chronic pain, experts have issued the first comprehensive guidelines on treating such suffering, Medscape reports. There is a link between chronic pain and poor quality of life, as well as poor adherence to antiretroviral treatment.

Categories: Chronic Pain

Medtronic launch spinal chord stimulation platform for chronic pain management following FDA approval

Chronic Pain - Tue, 09/19/2017 - 08:15

Medtronic plc announced FDA approval and U.S. launch of the Intellis platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation systems, such as battery performance, and can power the EvolveSM workflow*, which standardizes guidance and balances high-dose and low-dose therapy settings.

Categories: Chronic Pain

Nevro Corp. (NVRO) & SeaSpine Holdings Corporation (SPNE) Critical Analysis

Chronic Pain - Tue, 09/19/2017 - 01:23

Nevro Corp. and SeaSpine Holdings Corporation are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, institutional ownership and dividends. Nevro Corp. has a beta of -0.67, indicating that its stock price is 167% less volatile than the S&P 500.

Categories: Chronic Pain

Opioid Crisis Fast Facts

Chronic Pain - Mon, 09/18/2017 - 20:50

Experts say the United States is in the throes of an opioid epidemic, as more than two million of Americans have become dependent on or abused prescription pain pills and street drugs. Opioids are drugs formulated to replicate the pain reducing properties of opium.

Categories: Chronic Pain

LSU finalizes medical marijuana agreement with GB Sciences

Chronic Pain - Mon, 09/18/2017 - 16:15

Despite questions raised about the company's financial health, the LSU AgCenter has finalized its contract for GB Sciences Louisiana to produce medical cannabis products for the university. The company-a subsidiary of the Las Vegas-based biopharmaceutical firm GB Sciences Inc.-has already filed patent applications for cannabis that can be used to treat chronic pain, heart therapies and conditions like chronic arthritis, Crohn's disease, inflammatory bowel disease and asthma.

Categories: Chronic Pain

Beth Darnall receives funding to test pain management strategies

Chronic Pain - Mon, 09/18/2017 - 11:23

The Stanford pain psychologist will evaluate the effectiveness of behavioral training to help people with chronic pain reduce their use of opioids. Beth Darnall , PhD, clinical associate professor of anesthesiology, perioperative and pain medicine, has received an $8.8 million research award to study how to best help patients with chronic pain reduce opioids.

Categories: Chronic Pain

Will Chronic Pain Patients Survive The Opioid Epidemic?

Chronic Pain - Sat, 09/16/2017 - 03:02

Everywhere you turn today, you'll see reporting on the opioid epidemic, raising the alarm about overprescribing, community overdose rates, and attempts to control both legal and illegal use of opioids. Less frequently discussed, though, is the impact of new restrictions on chronic pain patients, many of whom rely on opioids to get through the day.

Categories: Chronic Pain

AAFP Names Top Physician, Education and Humanitarian Advocates

Chronic Pain - Fri, 09/15/2017 - 15:48

Two family physicians from across the nation were recognized for their outstanding contributions to family medicine and the health of the public. Each of these awards recognizes a family physician who have made exceptional advances in furthering the health of their communities through service and education.

Categories: Chronic Pain

Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel...

Chronic Pain - Thu, 09/14/2017 - 06:01

Levicept Ltd. , an asset-centric biotechnology company focused on the development of LEVI-04, a first-in-class treatment for chronic pain indications, today announces that it has commenced its Phase I trial of LEVI-04 in healthy volunteers and osteoarthritis patients at Hammersmith Medical Research, London UK. LEVI-04 is a proprietary p75 neurotrophin receptor fusion protein being developed by Levicept as a once-a-month injectable for the treatment of osteoarthritis and chronic pain.

Categories: Chronic Pain

Scientists reveal new insights and possible solutions for opioid epidemics using machine

Chronic Pain - Wed, 09/13/2017 - 01:51

Mount Sinai researchers have identified unique structural, biological and chemical insights in the way different opioid drugs activate the receptors and specific signaling pathways responsible for the drug's beneficial and adverse effects, according to a study to be published in Nature's Scientific Reports . Opioid overdoses are the leading cause of accidental death in the United States.

Categories: Chronic Pain

Study compares medical marijuana, prescription pills for chronic pain

Chronic Pain - Tue, 09/12/2017 - 21:13

A new UNM study shows smoking marijuana and ditching narcotics help people enrolled in the state's medical cannabis program deal with debilitating diseases. There are nearly 47,000 patients in New Mexico's Medical Cannabis program as of August 2017.

Categories: Chronic Pain

Pain Management Drugs and Devices Market, 2022

Chronic Pain - Tue, 09/12/2017 - 06:22

Dublin, Sept. 12, 2017 -- The "The Global Market for Pain Management Drugs and Devices" report has been added to Research and Markets' offering.

Categories: Chronic Pain

Bulk of opioid use in the U.S. concentrated among 10 percent of patients

Chronic Pain - Mon, 09/11/2017 - 23:35

A small proportion of opioid users account for the vast majority of opioid use in the United States. These findings suggest that efforts to reduce prescription opioid abuse should focus on the top users, rather than taking a population-based approach.

Categories: Chronic Pain

Opioid maker cites FDA decisions in defense against Ohio lawsuit

Chronic Pain - Mon, 09/11/2017 - 18:56

Major opioid maker Purdue Pharma is arguing that an Ohio lawsuit should be thrown out because the Food and Drug Administration approved the use of its popular painkiller. Ohio is among several states suing opioid makers, and claims these companies falsely marketed the drugs and downplayed the addictive effects of opioid painkillers that drove an epidemic still ravaging the United States.

Categories: Chronic Pain

Delos Therapy Opens Fourth Location in Oak Brook

Chronic Pain - Fri, 09/08/2017 - 18:35

OAK BROOK, IL, UNITED STATES, September 8, 2017 / EINPresswire.com / -- Chicago-based Delos Therapy is expanding its pain clinics with the opening of a new location on September 7th in the Oak Brook Promenade at 3011 Butterfield Road . A new and innovative therapy for treating chronic pain and muscle stiffness, Delos Therapy offers an alternative to traditional physical therapy, chiropractic or massage.

Categories: Chronic Pain

Nektar Presents Clinical Data From Phase III Summit-07 Study Of...

Chronic Pain - Thu, 09/07/2017 - 13:18

Nektar Presents Clinical Data From Phase III SUMMIT-07 Study Of NKTR-181, A First-In-Class Investigational Opioid To Treat Chronic Pain, At 2017 PAINWeek /PRNewswire/ -- Nektar Therapeutics today presented clinical data from the SUMMIT-07 Phase 3 study of NKTR-181, a first-in-class opioid analgesic to treat chronic pain, at the 2017 PAINWeekA Conference in . NKTR-181 is a new chemical entity and mu-opioid agonist molecule designed to provide potent pain relief without the high levels of euphoria that can lead to abuse and addiction with standard opioids.1 NKTR-181 is the first analgesic opioid molecule to exhibit reduction in specific CNS-mediated side effects, like euphoria, through the strategic alteration of brain-entry kinetics.

Categories: Chronic Pain

Chronic Pain Management: Moving Beyond Opioids

Chronic Pain - Thu, 09/07/2017 - 08:31

For years, physicians have relied on opioids as the first line of defense to help their patients living with chronic pain find relief . But what if these medications were treated as the last resort? The FDA recently released proposed changes to its blueprint for educating health care providers on treating chronic pain.

Categories: Chronic Pain

One overlooked method of stopping opioid addiction before it starts

Chronic Pain - Thu, 09/07/2017 - 01:44

In May, Dr. Scott Gottlieb, the new FDA Commissioner, declared the opioid epidemic his first and highest priority. And on his official blog, he has cited data unequivocally establishing prescription opioids as the main cause of opioid addiction.

Categories: Chronic Pain

Anaheim doctor disciplined in pain management case after patient has heart attack

Chronic Pain - Wed, 09/06/2017 - 16:33

An Anaheim anesthesiologist has been disciplined by the state Medical Board after a patient suffered a heart attack while receiving treatment for chronic pain under sedation. Dr. Edwin Kulubya agreed to five years of board probation to settle allegations of negligence, according to the board documents.

Categories: Chronic Pain

Your membership & donations make this ministry possible.
If you have been helped please:

Join Us  or  Donate

Contact Us

Syndicate content